European Medical Equipment Maintenance Market - Global Industry Dynamics

The objectives of this study are as follows:

# To define, describe, and forecast the European medical equipment maintenance market by device, service, service provider, contract type, end user, and country.

# To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.

# To forecast the size of the market segments with respect to European countries, namely, Germany, Italy, U.K., France, Spain, and Rest of Europe (RoE).

# To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies.

# To track and analyze competitive developments such as agreements, partnerships, collaborations, mergers & acquisitions, and expansions in the European medical equipment maintenance market

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243039217

On the basis of end user, private-sector organizations are to grow at the highest CAGR within the forecast period

By end user, the European medical equipment maintenance market is segmented into public sector organizations and private-sector organizations. In 2017, private-sector organizations are expected to register the highest CAGR during the forecast period. The increasing number of public- private partnerships is expected to boost the demand for medical equipment maintenance services in Europe.

Germany to dominate the market followed by Italy

By region, the European medical equipment maintenance market is segmented into Germany, Italy, UK, France, Spain, and RoE. In 2017, Germany accounted for the largest share of the market; this regional segment is also expected to grow at highest CAGR during the forecast period, followed by Italy. The high growth of the German market is attributed to the factors such as the significant presence of OEMs, growing medical technology market, well-established healthcare infrastructure and large installation base of medical equipment. Italy is the second largest growing market, factors such as focus on value-based healthcare system, and strategic expansion of market players, are expected to fuel the market growth in this country.

Partnerships, collaborations and agreements were the key growth strategies adopted by the market players to maintain and improve their position in the European medical equipment maintenance market.

Mergers & acquisitions accounted for the second largest share of the overall growth strategy mapped from 2014-2017. Some of the leading players who adopted this strategy include Hitachi, Ltd. (Japan), Medtronic plc (Ireland), and Pantheon Healthcare Group (Italy).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=243039217

The medical equipment maintenance market is highly competitive with several big and small players. The market, however, is dominated by the OEMs. Prominent OEMS in the medical equipment maintenance market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Toshiba Medical Systems Europe (Germany), and Drägerwerk AG & Co. KGaA (Germany); whereas, TBS Group S.p.A. (Italy), Pantheon Group (Italy), Technologie Sanitarie S.p.A. (Italy), Avensys UK Ltd. (U.K.), and Grupo Empresarial Electromédico (Spain) are some leading ISOs operating in the market.

European Hemostats & Sealants Market - Global Industry Dynamics | Major Leaders

The growth of this market is majorly driven by the launch of new products and favorable reimbursement scenario. However, the shift toward minimally invasive surgeries and adverse effect of hemostats are the major factors restraining the growth of this market.

The study involved four major activities to estimate the current size of the hemostats and sealants (focused brands) market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments.

The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=115823197

Major Objectives of This Study:

# To define, describe, and forecast the European hemostats and sealants market (by value) on the basis of focused brand and country.

# To identify micromarkets and the drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the focused brands market.

# To profile focused brands and comprehensively analyze their market shares in focused European countries.

Based on focused products, Tachosil is projected to register the highest growth during the forecast period

Based on focused products, the market is segmented into Tachosil, Lyostypt, Sangustop, Veriset, Avitene, and Hemopatch. Tachosil is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing demand for this product among end users.

Key questions addressed in the report:

# What are the growth opportunities in the hemostats and sealants market across major countries in Europe in the future?

# What are the key drivers and restraints in the hemostats and sealants market?

# What are the key brands in the hemostats and sealants market?

# Which are the key countries in the hemostats and sealants market?

# What are the most preferred brands amongst end users?

Germany commands the largest share of the market

Based on region, the hemostats and sealants (focused products) market is segmented into Germany, the UK, France, Italy, and Spain. Germany dominates the hemostats and sealants market due to its large patient population and the favorable reimbursement scenario for the usage of hemostats.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=115823197

Key players operating in the hemostats and sealants (focused products) market include B. Braun (Germany), Medtronic (Ireland), C. R. Bard (US), Takeda (Japan), and Baxter (US).

The market for hemostats and sealants is anticipated to grow mainly due to the launch of the new products, M&A’s, and favorable reimbursement scenario in Europe. However, the increasing preference for minimally invasive surgeries and the reducing preference for the usage of hemostats while performing surgeries are expected to hinder the growth of this market during the forecast year.

Medical Animation Industry is Expecting Major Innovations in Near Future

A number of factors such as rising adoption of medical animation by life sciences & medical device companies; entry of start-ups in the medical animation market; growing pharmaceutical/biopharmaceutical and medical devices industries; increasing penetration of smartphones, tablets, and other mobile platforms; and rising geriatric population and growing number of surgeries globally are expected to drive the growth of the medical animation market during the forecast period.

This report studies the global medical animation market for the forecast period of 2016 to 2021. This market is expected to reach USD 301.3 Million by 2021 from USD 117.3 Million in 2016, at a CAGR of 20.8%.

In this report, the global medical animation market is segmented on the basis of type, therapeutic area, application, end user, and region. Based on type, the medical animation market is categorized into 3D animation, 2D animation, real-time imaging (4D animation), and flash animation. The 3D animation segment is expected to account for the largest share of the medical animation market in 2016. However, the real-time imaging (4D animation) segment is projected to grow at the highest CAGR during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223188473

Based on therapeutic area, the medical animation market is segmented into oncology, cardiology, cosmeceuticals/plastic surgery, dental, and other therapeutic areas (ENT, gastroenterology, orthopedics, ophthalmology, neurology, and gynecology). The other therapeutic areas segment is expected to account for the largest share of the market in 2016; while, the cosmeceuticals/plastic surgery segment is projected to grow at the highest CAGR in the forecast period.

Target Audience:

# Medical Animation Service Providers

# Life Sciences Companies

# Medical Device Manufacturers

# Market Research and Consulting Firms

# Healthcare Service Providers

# Teaching Hospitals and Academic Medical Centers (AMCs)

# Medical Research Institutes

# Community Centers

# Regulatory Bodies

# Venture Capitalists

Based on application, the medical animation market is segmented into drug mechanism of action (MoA) and approval, patient education, surgical training and planning, cellular and molecular studies, and other applications (medical simulation, medical legal, forensic reconstruction, and emergency care instructions). The drug mechanism of action (MoA) and approval segment is expected to account for the largest share of the market in 2016; whereas, the patient education segment is projected to grow at the highest CAGR during the forecast period.

On the basis of end user, the medical animation market is segmented into life science companies; medical device manufacturers; hospitals, surgical centers, and clinics; academic institutes, and other end users (medico-legal firms, forensic departments, government bodies, and insurance companies). The life science companies segment is expected to account for the largest share of the market in 2016 and is projected to grow at the highest CAGR in the forecast period.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=223188473

Geographically, the global medical animation market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the medical animation market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is projected to grow at the highest CAGR, and serves as a revenue pocket for companies offering medical animation.

Major Industry Leaders:

Prominent players in the global medical animation market include Infuse Medical (U.S.), Hybrid Medical Animation, Inc. (U.S.), Ghost Productions, Inc. (U.S.), Scientific Animations, Inc. (U.S.), INVIVO Communications, Inc. (Canada), Random42 Scientific Communication (U.K.), Radius Digital Science (U.S.), Nucleus Medical Media, Inc. (U.S.), AXS Studio, Inc. (Canada), Visible Body (U.S.), Elara Systems, Inc. (U.S.), Animated Biomedical Productions (Australia), XVIVO Scientific Animation (U.S.), Blausen Medical Communications, Inc. (U.S.), Trinsic Medical Animation, LLC. (U.S.), Viscira (U.S.), Understand.com (U.S.), and Medmovie, Inc. (U.S.).

Laboratory Centrifuge Market - Global Leaders and Growth Strategies Adopted by Them

The laboratory centrifuges market is expected to reach USD 1.2 billion by 2023 from USD 1.1 billion in 2018, at a CAGR of 2.8%. Market growth is primarily driven by factors such as technological advancements, increasing research, and a high prevalence of target diseases.

However, the market faces major challenges in the form of mechanical failure of equipment (caused due to improper maintenance of rotors) and the release of harmful chemicals in the centrifugation of certain substances. The low replacement value of centrifuges (due to their long lifespans) may hinder market growth.

The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# Laboratory centrifuges revenue generated by the leading players have been determined through primary and secondary research processes.

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197749088

The laboratory centrifuges market has several big players. Key players in the market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), Sigma Laborzentrifugen GmbH (Germany), Andreas Hettich GmbH & Co. KG (Germany), Kubota Corporation (Japan), Koki Holdings Co., Ltd. (Japan) (previously Hitachi Koki Co., Ltd.), QIAGEN N.V. (Netherlands), NuAire (US), Sartorius (Germany), HERMLE Labortechnik GmbH (Germany), and Becton, Dickinson and Company (US).

These players have adopted various growth strategies, such as partnerships, agreements, and collaborations; and new product launches, to further expand their presence in the laboratory centrifuges market.

Product launches have been the key growth strategies adopted players from 2016 to 2018, which helped them to innovate on their offerings and broaden their customer base. Some of the leading players who adopted this strategy include Thermo Fisher Scientific Inc. (US), Eppendorf AG (Germany), and Danaher Corporation (US).

Recent Industry Developments:

# In 2016, Thermo Fisher Scientific launched Medifuge

# In 2016, Beckman Coulter partnered with Henry Ford Health System. This partnership aimed to enhance and streamline operations by fully automating the Henry Ford Hospital laboratory and modernizing the equipment at 12 other Henry Ford locations.

# In 2018, Eppendorf launched Centrifuge 5425

Thermo Fisher Scientific Inc. is one of the leading players in laboratory centrifuges market. The company’s strong brand recognition and extensive product portfolio in the laboratory centrifuges market is its key strength. To maintain a leading position in the market, Thermo Fisher has adopted product launches as its key organic growth strategy. Thermo Fisher has a robust promotional strategy in place and participates in various trade exhibitions, seminars, and workshops to promote its products. It is also supported by a strong sales force in over 180 countries.

Key Questions addressed by the report:

# Where will all these developments take the industry in the mid to long term?

# Which are the key players in the market and how intense is the competition?

# Which are the recent contracts and agreements key players have signed?

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=197749088

Eppendorf AG is one of the key players in the laboratory centrifuges market. The company’s leading position in the market can be attributed to its focus on product innovation. The company focuses on the development of its R&D capabilities, core competence, and on meeting customer and market demands.

This has allowed Eppendorf to introduce innovative products in the market. In the last two years, the company launched Centrifuge 5425, 5910 R, and refrigerated centrifuge 5920 R. This strengthened the company’s product portfolio and helped it to maintain its position in the market. The company has a strong presence across Europe, the Americas, APAC, and Africa. In 2018, the company launched Centrifuge 5425, 5910 R. This strengthened the company’s product portfolio and helped it to maintain its position in the market.

Emerging Markets in the Global Drug Discovery Services Industry

The study involved four major activities in estimating the current size of the drug discovery services market. Exhaustive secondary research was done to collect information on the market and its different subsegments.

The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research.

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes.

# All percentage shares split, and breakdowns have been determined using secondary sources and verified through primary sources.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=138732129

Report Objectives:

# To define, describe, and forecast the drug discovery services market based on process, type, drug type, therapeutic area, company type, and region.

# To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and trends).

# To strategically analyze micro-markets for individual growth trends, prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders operating in the market.

# To forecast the size of the market segments in four geographical regions, namely, North America, Europe, the Asia Pacific, and Rest of the World.

# To profile the key players and comprehensively analyze their services portfolios, market positions, and core competencies.

# To track and analyze competitive developments such as service launches, partnerships, collaborations, agreements, expansions, and acquisitions in the market.

North America is expected to command the largest share of the drug discovery services market in 2020.

Based on the region, the global drug discovery services market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America is expected to command the largest share of the drug discovery services market. The large share of this market segment can be attributed majorly to the presence of well-established CROs, rising R&D expenditure by pharmaceutical & biopharmaceutical companies, and the availability of latest techniques, instruments, and facilities for drug discovery research.

Key Questions Addressed in the Report:

# What are the growth opportunities in the market across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of drug discovery services. Will this scenario continue during the next five years?

# What are the various drug discovery services and their respective market shares in the overall market?

# What are the new trends and advancements in the market?

The major players operating in this market Laboratory Corporation of America Holdings (US), Albany Molecular Research, Inc. (US), Charles River Laboratories International, Inc. (US), Evotec SE (Germany), Eurofins Scientific (Luxembourg), WuXi AppTec (China), GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Pharmaceutical Product Development, LLC (US), Syngene International Ltd. (India), and Selvita S.A. (Poland) among others.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=138732129

Drug discovery services are provided by contract research organizations (CROs) to pharmaceutical companies (pharmaceutical companies outsource these services to CROs).

The drug discovery services market is fragmented and is dominated by various players as per the segments.

Recent Developments:

# In 2019, Charles River (US) and CHDI Foundation, Inc. (US), Extended collaboration on drug discovery and development for Huntington’s Disease by five years.

# In 2019, Laboratory Corporation of America Holdings’s (US) opened the Covance Drug Development segment opened a new R&D Center in Shanghai, China—its largest facility in the Asia Pacific. This will help the company to grow its business in China and the APAC.

Veterinary PoC Diagnostics Market - Emerging Industry Trends | Global Future Forecasts

The study involved four major activities in estimating the size of the global veterinary point-of-care diagnostics market. Exhaustive secondary research was done to collect information on the adoption of different technologies and their regional adoption trends. Industry experts further validated the data obtained through secondary research through primary research.

The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%.

Furthermore, the market size estimates and forecast provided in this study are derived through a mix of the bottom-up approach (country-level incidence data for various diseases) and top-down approach (assessment of utilization/adoption/penetration trends, by product, technology, application, animal type, and end user). After that, market breakdown and data triangulation methods were used to estimate the market size of segments and subsegments.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105329994

Recent Developments:

# In 2019, IDEXX Laboratories launched a Canine Progesterone Test for Catalyst Dx and Catalyst One Chemistry Analyzers.

# In 2019, Zoetis, Inc. launched Stablelab, a handheld point-of-care diagnostic blood test for equine.

# In 2019, FUJIFILM SonoSite partnered with Partners Healthcare (US) to enable clinicians to perform scans at point of care.

# In 2019, Eurolyser partnered with Sysmex Corporation (Japan) to sell Eurolyser’s point of care systems measuring CRP.

Growth in the companion animal population, rising demand for pet insurance, increasing number of veterinary practitioners in developed economies, and technological advancements are some of the factors driving the growth of this market during the forecast period.

By end user, the veterinary clinics segment accounted for the largest share of the veterinary point-of-care diagnostics market in 2018

Based on end user, the market is segmented into veterinary hospitals & academic institutes, veterinary clinics, and home care settings. In 2018, the veterinary clinics segment accounted for the largest share of the market. The large share of this segment is attributed to the growing number of patients visiting vet clinics and the increasing number of private clinical practices.

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the global veterinary point-of-care diagnostics market?

# What covers the drivers, restraints, opportunities, and challenges in the veterinary point-of-care diagnostics industry?

# What are the new technological advancements in the veterinary point-of-care diagnostics market?

# Comment on the regulatory scenario for the veterinary point-of-care diagnostics industry in various geographies.

# What are the growth trends in the veterinary point-of-care diagnostics market at the segmental and overall market levels?

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=105329994

North America will continue to dominate the market during the forecast period

The market, by region, is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the veterinary point-of-care diagnostics market in 2018. The large share of North America in the global market can be attributed to the increasing adoption of companion animals, growing veterinary healthcare expenditure, and rising demand for animal-derived food products.

In 2018, IDEXX Laboratories, Inc. (US) and Zoetis, Inc. (US) dominated the global veterinary point-of-care diagnostics industry, accounting for more than ~80–85% of the total market share.

Some of the other prominent players operating in the veterinary point-of-care diagnostics market are Heska Corporation (US), Virbac (France), Thermo Fisher Scientific, Inc. (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company (UK), Randox Laboratories LTD. (UK), AniPOC, Ltd. (UK), Carestream Health, Inc. (a part of ONEX Corporation) (Canada), NeuroLogica Corporation (a part of Samsung Electronics Co. Ltd.) (South Korea), and FUJIFILM SonoSite (a part of FUJIFILM Holdings Corporation) (Japan).

Healthcare Cloud Computing Market - Global Growth Dynamics

The growth of this market is primarily attributed to the increasing adoption of big data analytics, wearable devices, and IoT in healthcare and the advantages of cloud usage, such as improved storage, flexibility, and scalability of data.

The global healthcare cloud computing market is projected to reach USD 51.9 billion by 2024, from an estimated USD 23.4 billion in 2019 at a CAGR of 17.2% during the forecast period.

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=347

Recent Developments:

# In 2019, NTT DATA and Google Cloud announced a joint go-to-market strategy to provide consulting, implementation, and managed services to clients seeking digital transformation. Google Cloud enhanced NTT DATA’s cloud transformation offerings by adding more Google Cloud resources in analytics, artificial intelligence, machine learning, cloud migration, IoT, security, and productivity.

# In 2019, IBM acquired Red Hat, which is a landmark acquisition for USD 34 billion. The addition will enhance IBM’s hybrid cloud portfolio and aim to develop a next-generation multi-cloud hybrid platform.

# In 2018, DXC Technologies acquired TESM (UK) to expand the range of cloud-based solutions and enterprise software as a service solution. This enabled DXC to address customer needs across the Europe region.

North America dominated the market in 2018

In 2018, North America accounted for the largest share of the global healthcare cloud computing market, followed by Europe. Factors such as the increasing adoption of Electronic Health Records (EHRs) among medical professionals, the incentive-driven approach of government health IT programs, and active participation by private sector players in industry development contribute to the largest share of this region.

Critical Questions Answered in the Report:

# How will the current technological trends affect the healthcare cloud computing market in the long term?

# What are the reasons contributing to the growth of the provider and payer solutions in the market?

# Which regions are likely to grow at the highest CAGR in the global market?

# What are the challenges hindering the adoption of healthcare cloud computing in the market?

# What are the growth strategies being implemented by major market players?

Market Size Estimation:

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product, deployment model, component, pricing model, service model, and region).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=347

IBM (US), Siemens Healthineers (Germany), and Carestream Health (US) are the leading players in the global healthcare cloud computing industry. Other prominent players operating in the healthcare cloud computing market include Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), NTT Data Corporation (Japan), Fujifilm Holdings Cooperation (Japan), Dell (US), Allscripts Healthcare Solutions (US), athenahealth (US), DXC Technology Company (US), Vepro eHealth Solutions (Germany), Orion Health Group (New Zealand), NextGen Healthcare (US), Sectra AB (Sweden), Hyland Software Inc. (US), and EnSoftek Inc.(US).

With a reliable brand name, IBM was one of the leading players in the global healthcare cloud computing market for 2018. The company has a strong presence in the commercial and government healthcare markets. The company offers a robust portfolio of products and services in the market. In order to strengthen its portfolio, IBM focuses on enhancing its products & services and investing in research activities to continuously improve its product portfolio.

Siemens Healthineers is another key player in the global healthcare cloud computing market. The company provides technology solutions to the healthcare, pharmaceutical, and life sciences markets. The company offers medical technologies, software solutions, and clinical consulting services. Siemens Healthineers focuses on R&D activities and develops innovative product lines using artificial intelligence.

Respiratory Care Devices Market to Experience Good Times in Near Future

Rising demand for enhanced portable and compact respiratory care devices, key players focusing on expanding their geographical reach, rising demand for multimodal ventilation, and the rising adoption of non-invasive ventilation are the key trends in market.

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the market?

# What are the drivers, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the market?

# What are the growth trends in the market at the segmental and overall market levels?

# How is the market performing in different regions across the globe?

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368

The global respiratory care devices market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1% during the forecast period.

The therapeutic respiratory care devices accounted for the largest share of the respiratory care devices market in 2018. The increasing prevalence of chronic respiratory diseases and the growing geriatric population are driving the growth of this market. Growth in the geriatric population is expected to drive the demand for therapeutic devices such as nebulizers, oxygen concentrators, humidifiers, and PAP devices.

Recent Developments:

# In May 2019, Fisher Paykel (New Zealand) launched a nasal cannula - F&P Optiflow 3S, to strengthen its position in the therapeutic respiratory care devices market.

# In March 2019, ResMed acquired HB Healthcare Safety, a provider of home-based medical equipment for sleep and respiratory care devices.

# In March 2018, Philips opened its first Sleep and Respiratory Education Center in Singapore.

# In May 2019 Masimo Corporation (US) signed an agreement with Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China) to offer Masimo SET Measure-through Motion and Low Perfusion pulse oximetry in its monitoring devices. Mindray devices equipped with SET will now be available in select countries in Europe, the Middle East, Russia, the Commonwealth of Independent States, and the Asia Pacific (excluding China), including Australia and India.

Market Share Estimation:

The market shares for leading respiratory care devices companies was arrived at after a detailed assessment of their revenues from the respiratory care devices business by secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases revenue share was arrived at after detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with various industry experts.

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=368

The market in the Asia Pacific region is expected to be the fastest growing in 2019

While the respiratory care devices market in the APAC is relatively smaller than developed markets across North America and Europe, it is expected to grow at the highest rate. This can be attributed to the presence of high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. 

In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and the expansion of private-sector hospitals to rural areas are major factors driving the growth of the respiratory care devices market. Low labor costs and the favorable regulatory environment in the region will also contribute.

The respiratory care devices market is fragmented in nature, with the top five players accounting for around half of the total market in 2018. There are other smaller and medium-sized players as well, operating at both global and regional levels. The leading market players are based across developed countries such as the US, the Netherlands, New Zealand, and Ireland.

However, in the past few years, smaller players have emerged, especially in the Asia Pacific market, competing with global players on the basis of price. Lucrative growth opportunities in the Asia Pacific market are increasing competition among market players. Companies are also focusing on R&D to add innovative technologies and products to their portfolios, which, in turn, helps them to strengthen their presence in respective markets.

Read the Detailed Article@ 

https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Clinical Trial Management System Market - Global Growth Prospects

Market Dynamics:

Factors such as significant partnerships between biopharma companies and CROs, rising number of clinical trials, availability of advanced CTMS solutions, growing customer base for CTMS solutions, and rising government funding & grants to support clinical trials are driving the overall demand for CTMS across key markets.

However, budget constraints and limited awareness among researchers about the advantages of CTMS solutions are the major factors restraining the growth of CTMS market.

Driver: Rising number of clinical trials to drive the CTMS market

The life science industry is witnessing a global increase in the number of clinical trials each year.

This growth in the number of clinical trials conducted can be attributed to factors such as the rapidly increasing aging population, high prevalence of chronic diseases, expiry of blockbuster drugs, availability of government funds for clinical trials, and fierce competition in the pharmaceutical industry. According to ClinicalTrials.gov, as of December 06, 2017, 260,848 clinical trials were registered across the globe.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=470

The global CTMS market is expected to reach $1,928.9 million by 2027 from $590.0 million in 2017, at a CAGR of 12.6%. The major factors driving the growth of the CTMS market include the significant partnerships between Asian CROs and pharma companies, rising number of clinical trials in both developing and developed nations, availability of advanced and upgraded CTMS solutions, and rising government support for clinical trials in Asian countries. 

Key questions addressed in the report:

# What are the growth opportunities related to CTMS market across major regions in the future?

# Emerging countries have immense opportunities for the growth and adoption of enterprise CTMS products. Will this scenario continue in the next five years?

# What are the various types of CTMS products and their market share in the overall market?

# What are the new trends and advancements in the clinical trials industry?

Restraint: Limited awareness among researchers about the advantages of CTMS solutions

Several investigators are either unaware or ignorant of the benefits of CTMS over traditional paper-based work or spreadsheets method. Clinical trial investigators need to understand the prospects of these tools which enhance the clinical trial process and help manage it effectively. This limited awareness in the research community is consequently limiting the adoption of CTMS solutions.

Recent Developments:

# In November 2017, Bio-Optronics and Complion entered into a partnership in order to integrate and develop their solutions, namely, CTMS and eRegulatory Solutions

# In September 2017, Pamplona completed the acquisition of Paraxel and bought its shares in order to help PARAXEL increase its productivity.

# In May 2017, Oracle opened its Oracle Cloud EU Region in Germany, with the addition of modern infrastructure as a service (IaaS) architecture and new IaaS and platform as a service (PaaS) cloud services.

# In January 2017, MedNet Solutions released the latest version of iMedNet with enhanced features

# In June 2016, Bio-Optronics launched the latest version of the Clinical Conductor CTMS.

Request Sample pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=470

North America is expected to dominate the CTMS market during the forecast period

Geographically, the CTMS market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America is expected to account for the largest share of the global CTMS market during the forecast period (2017-2027). Factors such as rising number of on-going clinical trials (especially in the US), presence of leading players from both demand and supply sides, and government funding for clinical research are contributing to the large share of the North American region.

The major players operating in the clinical trial management system market include Oracle (US), Medidata Solutions (US), PAREXEL (US), Bioclinica (US), Bio-Optronics (US), and IBM (US).

Analysis of the market developments between 2014 and 2017 revealed that several growth strategies such as product launches, enhancements, strategic acquisitions, agreements, partnerships, collaborations, and expansions were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the CTMS market. Among these business strategies, product enhancements, agreements, and partnerships were the most widely adopted growth strategies by the players in the CTMS market.

Surgical Imaging Industry is Expecting Major Revolution in Near Future

Target Audience for this Study:

# C-arms manufacturers and distributors

# Healthcare institutions 

# Medical device vendors/service providers

# Research institutes

# Niche companies manufacturing imaging systems

# Research and consulting firms

# Venture capitalists

The surgical imaging market is expected to reach USD 1.63 Billion by 2022 from an estimated USD 1.25 Billion in 2017, at a CAGR of 5.5%.

The key factors driving the growth of this market are growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and increasing demand for minimally invasive procedures.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=210534462

North America to dominate the market in 2017

North America is expected to account for the largest share of the surgical imaging market in 2017, followed by Europe, Asia Pacific (APAC), and the Rest of the World. The large share of this region can be attributed to a rising number of overuse sports injuries, and rising prevalence of CVD, along with the increasing number of cardiac arrest cases, and increase in the number of minimally invasive procedures performed in Canada.

However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, owing to the rapid growth in geriatric population in Japan, healthcare reforms in China, improving healthcare infrastructure in India, and rising number of orthopedic and CVD procedures in Australia.

The following are the major objectives of the study:

# To describe and forecast the surgical imaging market, in terms of value, by technology, application, and region.

# To describe and forecast the market, by region–Asia Pacific (APAC), Europe, North America, and Rest of the World (RoW) along with their respective countries.

# To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

# To study the complete value chain of surgical imaging.

# To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the surgical imaging ecosystem.

# To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, along with detailing competitive landscape for market leaders.

# To analyze strategic approaches such as partnerships, agreements, alliances, collaborations, product launches, expansions, and acquisitions in the market.

The surgical imaging market is emerging and fragmented in nature with various regional and international players. In 2016, the surgical imaging market was dominated by a few large players and several small players. Players in this market compete with each other to deliver superior quality products that are technologically advanced and to provide well-regulated customer service functions. Major companies in this market are GE Healthcare (UK), Siemens AG (Germany), Koninklijke Philips (Netherlands), and Ziehm Imaging (Germany).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=210534462

Major Market Developments:

# In 2017, Koninklijke Philips partnered with Government of Kenya and the United Nations to Establish the SDG (Sustainable Development Goals) Partnership Platform in Kenya to make primary healthcare more accessible.

# In 2017, Koninklijke Philips established its first innovation center in Moscow, Russia.

# In 2017, Siemens Received US FDA approval for its Cios Fusion, Cios Connect, and Cios Select.

# In 2017, Ziehm Imaging Launched the new version of Ziehm Vision FD with a complementary metal oxide semiconductor (CMOS) flat-panel detector and a new CMOS flat-panel detector which allows for display of smaller pixels in the same quality.

# In 2016, Shimadzu Corporation established an indirectly-owned subsidiary—Shimadzu Malaysia Sdn Bhd.

Agreements, collaborations, alliances, and partnerships were the key strategies adopted by players from 2014–2017. The players that adopted these strategies are Koninklijke Philips, Ziehm Imaging, GE Healthcare, Siemens, OrthoScan, Toshiba Medical Systems, and Medtronic. Koninklijke Philips accounted for a share of 38% of the total number of agreements, collaborations, alliances, and partnerships in the surgical imaging market. 

This high share of the company can be attributed to its increasing number of partnerships and collaborations with hospitals which are the primary end users of C-arms.

Read More Detailed Article@ https://bit.ly/2ZhD4m7

Human Liver Models Market - Growing Healthcare Market in the Asia Pacific and Latin America

Objectives of this Study:

# To define, measure, and describe the global human liver model market by type and region.

# To provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities).

# To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.

# To forecast the size of market segments in North America, Europe, Asia Pacific, and RoW

The global human liver models market is expected to reach USD 2.56 Billion by 2022 from USD 1.35 Billion in 2017, at a CAGR of 13.6% during the forecast period (2017-2022).

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468

The key factors driving the growth of this market include growing focus on developing alternatives for animal testing models, significant increase in research funding and venture capital investments for the development of liver models, growing initiatives to increase awareness about liver organoids, increasing research activities on liver organoids, increasing prevalence of non-alcoholic fatty liver disease, and growing need for the early detection of drug toxicity to minimize financial losses due to late-stage drug failure.

Target Audience:

# Pharmaceutical and biotechnology companies

# Chemical companies

# Cosmetic product manufacturers, suppliers, and distributors

# Healthcare providers and diagnostic laboratories

# Manufacturers of 3D Cell Culture products

# Food & beverage manufacturers

# Contract research organizations (CROs)

# Research institutes/universities

# Research and consulting firms

# Venture capitalists

North America held the largest share of the market in 2017

In 2017, North America accounted for the largest share of the human liver models market, followed by Europe.

The market for human liver models in this region is driven by the presence of a well-established life sciences industry, growing awareness about the organoids technology, favorable government initiatives, growing incidence of NAFLD, and unavailability of livers for transplantation, increased research spending, rising focus on tissue culture-based clinical diagnostics, and the availability of skilled professionals.

The human liver models market is emerging and fragmented in nature with various regional and international players. In 2016, the liver-on-a-chip and liver 3D bioprinting market was dominated by CN Bio (UK) and Organovo Holdings, Inc. (US), respectively.

The key players in the global human liver models market are Emulate (US), Ascendance Bio (US), HìREL (US), CN Bio (UK), Organovo (US), and Cyfuse Biomedical (Japan).

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468

Major Growth Boosters for the Global Respiratory Care Devices Industry

The study involved 4 major activities in estimating the current market size for the respiratory care devices market. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

The Global Respiratory Care Devices Market is projected to reach USD 31.8 billion by 2024 from USD 20.6 billion in 2019, at a CAGR of 9.1%.

Both the top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Key Questions Addressed in the Report:

# Who are the top 10 players operating in the market?

# What are the drivers, restraints, opportunities, and challenges in the market?

# What are the industry trends as well as the current scenario in the market?

# What are the growth trends in the market at the segmental and overall market levels?

# How is the market performing in different regions across the globe?

Download PDF Brochure

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=368

The emergence of home healthcare has opened new growth avenues for the respiratory care devices market. Convenience and comfort in a home care environment, coupled with cost advantages, are the major factors driving the growth of the home healthcare market for respiratory care devices.

The major factor driving the growth of the respiratory care devices market is the high prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population, high prevalence of tobacco smoking, urbanization and growing levels of pollution, and changing lifestyles.

Market Share Estimation:

The market shares for leading respiratory care devices companies was arrived at after a detailed assessment of their revenues from the respiratory care devices business by secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases revenue share was arrived at after detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with various industry experts.

Objectives of this study:

# To define, describe, segment, and forecast the global respiratory care devices market on the basis of product, indication, end user, and region.

# To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and industry-specific challenges).

# To analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market.

# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market players.

# To forecast the size of the market, in five main regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

# To profile key players in the global market and comprehensively analyze their core competencies and market shares.

# To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global market.

Data Triangulation:

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=368

The market in the Asia Pacific region is expected to be the fastest growing in 2019

While the respiratory care devices market in the APAC is relatively smaller than developed markets across North America and Europe, it is expected to grow at the highest rate. This can be attributed to the presence of high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore.

In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, rising demand for cutting-edge technologies, and the expansion of private-sector hospitals to rural areas are major factors driving the growth of the respiratory care devices market. Low labor costs and the favorable regulatory environment in the region will also contribute.

The respiratory care devices market is fragmented in nature, with the top five players accounting for around half of the total market in 2018. There are other smaller and medium-sized players as well, operating at both global and regional levels. The leading market players are based across developed countries such as the US, the Netherlands, New Zealand, and Ireland.

However, in the past few years, smaller players have emerged, especially in the Asia Pacific market, competing with global players on the basis of price. Lucrative growth opportunities in the Asia Pacific market are increasing competition among market players. Companies are also focusing on R&D to add innovative technologies and products to their portfolios, which, in turn, helps them to strengthen their presence in respective markets.

The key players in the global respiratory care devices market are Philips Healthcare (Netherlands), ResMed Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Chart Industries (US), Drager AG (Germany), Invacare Corporation (US), Getinge AB (Sweden), Air Liquide (France), Hamilton Medical AG (Switzerland), Vyaire Medical (US), GE Healthcare (US), Nonin Medical Inc. (US), Apex Medical Corp. (Taiwan), Smiths Group (UK), Omron Healthcare Inc. (US), Allied Healthcare Products, Inc. (US), Teleflex Incorporated (US), and DeVilbiss Healthcare LLC (US).

Read More Detailed Article@

https://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Animal Parasiticides Market - Expected Revenue Growth & Global Industry Future Forecasts

Target Audience:

# Animal Parasiticides Manufacturers

# Animal Parasiticides Distributors

# Animal Health Research & Development (R&D) Companies

# Government Associations

# Research and consulting firms

# Venture Capitalists and Investors

In 2014, ectoparasiticides accounted for the largest share of the global animal parasiticides market and this segment is expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the advantages offered by ectoparasiticides over other parasiticide formulations.

The animal parasiticides market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 5.7% between 2015 and 2020 to reach 9.75 Billion by 2020.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258895412

The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, increasing number of veterinary practitioners and their growing income levels in developed regions, increasing number of animal research activities along with growing research grants, and rising awareness about zoonotic diseases.

Critical questions the report answers:

# What are the geographic growth opportunities in the animal parasiticides market?

# How growing consolidation in the animal health industry will impact the animal parasiticides market in future?

Europe is the largest regional segment for animal parasiticides owing to the well-established animal healthcare market and growing R&D activities in this region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising pet adoption and increasing demand for animal-derived food products in India and China.

Some major mergers and acquisitions by Global Leaders are summarized below:

# In March 2015, Perrigo Company PLC (US) acquired Omega Pharma Invest N.V. (Belgium) for USD 4.61 million. This acquisition helped the company to enhance its presence across the globe.

# Zoetis, Inc. (US) acquired animal health assets of Abbott Laboratories (US) for USD 255 million, in February 2015. This acquisition expanded Zoetis’ companion animal product portfolio

# In January 2015, Eli Lilly and Company (US) acquired Novartis Animal Health (Switzerland). This acquisition helped the company strengthen its product portfolio and expanded its global commercial presence.

# In April 2014, Vetoquinol S.A. (France) acquired the animal health business of Bioniche Life Sciences Inc. (Canada). This acquisition helped Vetoquinol to leverage its existing animal healthcare product portfolio as well as its geographic presence.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=258895412

Major Leaders:

The market players, namely, Sanofi (France), Bayer AG (Germany), and Zoetis, Inc. (U.S.) together accounted for the largest share of the animal parasiticides market and will continue to dominate the market between 2015 and 2020.

Rheometer & Viscometer Market - Emerging Technological Innovations

Years Considered for the Study:

# Base Year: 2017

# Forecast Period: 2018–2023

The demand for rheometers and viscometers across key markets is majorly driven by factors such as technology advancements; expansion of petrochemical and material manufacturing industries; growing stringency of the regulatory framework for product safety compliance in cosmeceutical, biotechnology, and pharmaceutical industries; rising public-private investments to support product innovation; and increasing burden of target diseases, globally. However, the high cost of viscometers and rheometers is expected to restrain the growth of this market during the forecast period.

The report studies the global rheometers and viscometers market over the forecast period from 2018 to 2023. The market is projected to reach USD 878.6 million by 2023 from USD 721.5 million in 2018, at a CAGR of 4.0%.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93584044

Objectives of the Study:

# To define, describe, and forecast the global viscometer market by product, sample type, end user, and region.

# To provide detailed information about the major factors influencing market growth (key drivers, restraints, opportunities, and industry-specific challenges).

# To strategically analyze micromarkets with respect to individual growth trends, prospects, and their contributions to the global viscometer market.

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key global players.

# To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe [Germany, France, the UK, and Rest of Europe (RoE)], Asia Pacific [China, India, Japan, and Rest of Asia Pacific (RoAPAC)], and the Rest of the World (RoW).

# To profile the key players active in the global rheometers and viscometers industry and comprehensively analyze their global revenue shares and core competencies.

# To track and analyze competitive market-specific developments such as product developments & commercialization, strategic mergers, market expansions, as well as agreements in the global rheometers and viscometers industry

North America is expected to dominate the rheometers and viscometers market in 2018.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The large share of North America can be attributed to ongoing technological advancements in the field of rheometers & viscometers, the wide availability of rheometers and viscometers in the region (owing to the strong distribution networks of major product manufacturers in North America), and the strong presence of major device manufacturers.

Analysis of the market developments between 2014 and 2018 reveals that several growth strategies, such as product launches, expansions, mergers, and agreements were adopted by the market players to strengthen their product portfolios and maintain a competitive position in the rheometers and viscometers market. Among these business strategies, product launches and market expansions were the most widely adopted growth strategies by players in the market.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=93584044

Major Stakeholders of the Global Industry:

# Rheometer and viscometer manufacturing companies

# Pharmaceutical, biotechnology, and cosmeceutical companies

# Petroleum manufacturers and petrochemical refineries

# Food processing companies and beverage manufacturers

# Chemical and material manufacturers

# Environmental testing, food testing, and forensic analysis laboratories

# Product sales and distribution companies

# Research and development companies

# Research laboratories and academic institutes

# Clinical research organizations (CROs)

# Government and non-governmental regulatory authorities

# Independent national and international associations

# Diagnostic and forensic testing laboratories

# Market research and consulting firms

Molecular Biology Enzymes Research - Global Industry Growth Dynamics

Growth in the molecular biology enzymes and kits & reagents market is driven by factors such as increased research activities and R&D investments in the life science industry, rising number of genome projects, technological advancements in the life science industry, and rising incidence of infectious diseases & genetic disorders. However, limited reimbursements for genetic testing is expected to restrain the growth of this market during the forecast period.

Target Audience:

# Molecular Biology Enzymes and Kits & Reagents Manufacturers and Vendors

# Associations Related to Molecular Biology Enzymes and Kits & Reagents

# Contract Research Organizations (CROs)

# Research Institutes and Academic Centers

# Pharmaceutical and Biopharmaceutical Companies

# Business Research and Consulting Service Providers

# Venture Capitalists

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8% during the forecast period.

Download PDF Brochure@

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164131709

Based on end user, the market is segmented into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies, and other end users (contract research organizations (CROs), food & beverage companies, and forensic agencies).

The academic & research institutes segment is expected to command the largest share of the molecular biology enzymes and kits & reagents market in 2017. The large share of this segment can be attributed to the increasing research activities backed by funding from government and private organizations.

Objectives of the Study:

# To define and measure the global molecular biology enzymes and kits & reagents market on the basis of product, application, end user, and region.

# To identify key micromarkets and their drivers within the global molecular biology enzymes and kits & reagents market, which are expected to offer impressive growth opportunities in the coming years.

# To identify trends and opportunities for stakeholders in the market and provide details of the competitive landscape for major market leaders.

# To provide detailed information regarding the major factors influencing market growth (drivers, restraints, challenges, and opportunities).

# To forecast the size of the market segments with respect to four main regions, namely, North America (US and Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of APAC), and the Rest of the World (Latin America and Middle East & Africa)

# To analyze the market structure and profile key players in the global molecular biology enzymes and kits & reagents market and comprehensively evaluate their core competencies.

# To track and analyze competitive landscape such as market share analysis and competitive leadership

North America to dominate the market in 2017

In 2017, North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market, followed by Europe, Asia Pacific (APAC), and the Rest of the World (Latin America and the Middle East & Africa). Factors such as increasing research funding for genomics research, rising number of pharmaceutical and biotechnology companies, favorable reimbursement scenario for molecular diagnostics, and growing prevalence of target indications are contributing to the large share of North America.

Request Sample Pages@

https://www.marketsandmarkets.com/requestsampleNew.asp?id=164131709

In 2016, Thermo Fisher (US), Merck (Germany), and Illumina (US) held a share of 70% to 75% of the overall market.

The key players in the global molecular biology enzymes and kits & reagents market are Thermo Fisher (US), Merck (Germany), Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).